The present invention relates to new compounds of formula I, (I) wherein R
1
to R
4
, m, n and p, are as defined as in formula I, or salts, solvates or solvated salts thereof, processes for their preparation and to a new intermediate used in the preparation thereof, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.
本发明涉及一种新的化合物I,其
化学式为(I),其中R1至R4,m,n和p如
化学式I中所定义,或其盐,溶剂合物或溶剂化盐,其制备方法以及用于其制备的新中间体,含有该化合物的药物制剂以及该化合物在治疗中的应用。